As of the latest SEC filings, Drugs Made In America Acquisition Corp. (DMAAR) is held by 6 institutional funds. The largest fund shareholder is The Merger Fund (MERIX), holding an estimated $25,267.26 in market value, representing a significant portion of its portfolio.
Funds holding Drugs Made In America Acquisition Corp. (DMAAR)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- DMAAR
- CIK:
- 0002028614
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
MERIX
The Merger Fund
|
MF | Independent / Boutique | 0.00% | $25,267.26 | 458,571 | Mar 31, 2026 | May 29, 2026 |
|
RIV
RiverNorth Opportunities Fund Inc.
|
CEF | Independent / Boutique | 0.00% | $6,040.00 | 100,000 | Mar 31, 2026 | May 28, 2026 |
|
SPE
Special Opportunities Fund, Inc.
|
CEF | Independent / Boutique | 0.00% | $2,389.36 | 43,364 | Mar 31, 2026 | Jun 1, 2026 |
|
-
JNL Multi-Manager Alternative Fund
|
ETF | Independent / Boutique | 0.00% | $1,381.14 | 25,066 | Mar 31, 2026 | May 28, 2026 |
|
SPAQ
Horizon Kinetics SPAC Active ETF
|
ETF | Independent / Boutique | 0.01% | $1,262.84 | 22,919 | Mar 31, 2026 | May 22, 2026 |
|
WCFRX
Virtus Westchester Credit Event Fund
|
MF | Duff & Phelps / Virtus | 0.00% | $901.60 | 16,363 | Mar 31, 2026 | May 29, 2026 |
Advertisement (320x50)